We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Mindful Steps: Promoting Physical Activity

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03003780
Recruitment Status : Completed
First Posted : December 28, 2016
Last Update Posted : January 9, 2023
Information provided by (Responsible Party):
Gloria Y. Yeh, Beth Israel Deaconess Medical Center

Brief Summary:
This is a developmental project with two phases. The first phase will adapt an existing web-based intervention to incorporate mind-body exercises to develop a multi-modal intervention to promote physical activity in patients with COPD and HF. The second phase will pilot test this new intervention in a longitudinal study (subjects randomized to intervention or usual care).

Condition or disease Intervention/treatment Phase
Copd Heart Failure Behavioral: Mindful Steps Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 42 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Mindful Steps: Coupling Technology and Mind-Body Exercise to Facilitate Physical Activity in Patients With Cardiopulmonary Disease
Actual Study Start Date : January 2, 2019
Actual Primary Completion Date : July 6, 2021
Actual Study Completion Date : July 6, 2021

Arm Intervention/treatment
Experimental: Mindful Steps
Web-based behavioral intervention
Behavioral: Mindful Steps
Integrated website, activity tracker, and mind-body training

No Intervention: Usual Care

Primary Outcome Measures :
  1. Feasibility [ Time Frame: 6 months ]
    intervention acceptability (qualitative interview)

Secondary Outcome Measures :
  1. Self-efficacy [ Time Frame: baseline, months 3, 6, 9 and 12 ]
    change in self-efficacy between time points (exercise self-efficacy scale)

  2. Physical activity [ Time Frame: baseline, months 3,6,9, and 12 ]
    change in physical activity between time points (physical activity questionnaire)

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Clinical diagnosis of COPD OR clinical diagnosis of HF syndrome (New York Heart Association Class 1-3)
  • Able to participate in an exercise program
  • Have an active email account and access to a computer with internet connection

Exclusion Criteria:

  • COPD or HF exacerbation in the previous month
  • Inability to ambulate
  • Clinical signs of unstable cardiovascular disease
  • Hypoxemia during 6MWT
  • Inability to collect at least 7 of 14 days of baseline step counts
  • Current participation in a cardiac or pulmonary rehabilitation program.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03003780

Layout table for location information
United States, Massachusetts
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Beth Israel Deaconess Medical Center
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Gloria Y. Yeh, Associate Professor of Medicine, Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier: NCT03003780    
Other Study ID Numbers: 2016P000368
First Posted: December 28, 2016    Key Record Dates
Last Update Posted: January 9, 2023
Last Verified: January 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases